Host genetic determinants of HIV pathogenesis: an immunologic perspective
- 1 May 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in HIV and AIDS
- Vol. 3 (3) , 342-348
- https://doi.org/10.1097/coh.0b013e3282fbaa92
Abstract
The purpose of this review is to highlight recent advances in our understanding of host genetic determinants of HIV pathogenesis and to provide a theoretical framework for interpreting these studies in the context of our evolving understanding of HIV immunopathogenesis. The first genome-wide association analysis of host determinants of HIV pathogenesis and other recent studies evaluating the interaction between killer cell immunoglobulin-like receptors and human leukocyte antigen alleles have implicated both adaptive and innate immune responses in the control of HIV replication. Furthermore, genetic variation associated with the expression of CCR5 and its ligand have been strongly associated with both decreased susceptibility to HIV infection and delayed clinical progression, independent of their effects on viral replication, suggesting a potential role for CCR5 inhibitors as immune-based therapies in HIV disease. Host factors associated with the control of HIV replication may help identify important targets for vaccine design, while those associated with delayed clinical progression provide targets for future immune-based therapies against HIV infection.Keywords
This publication has 58 references indexed in Scilit:
- Relationship between T Cell Activation and CD4+T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of TherapyThe Journal of Infectious Diseases, 2008
- Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypesThe Journal of Experimental Medicine, 2007
- A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1Science, 2007
- Low Immune Activation despite High Levels of Pathogenic Human Immunodeficiency Virus Type 1 Results in Long-Term Asymptomatic DiseaseJournal of Virology, 2007
- Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1Nature Genetics, 2007
- Nef interference with HIV-1–specific CTL antiviral activity is epitope specificBlood, 2006
- Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hostsBlood, 2006
- Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutationsThe Journal of Experimental Medicine, 2006
- Genome-Wide Associations of Gene Expression Variation in HumansPLoS Genetics, 2005
- Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progressionGenes & Immunity, 2005